Evidence of tau pathology in the brains of patients with DLB has been reported through antibody-based analyses of post-mortem tissues, further corroborated by cerebrospinal fluid (CSF) analysis [6, 7]. This evidence concerns the gene MAPT and Lewy body dementia.